
|Videos|January 21, 2021
The Asenapine Transdermal System
Author(s)Leslie L. Citrome, MD, MPH
The first-and-only transdermal patch for adults with schizophrenia offers a new treatment.
Advertisement
Leslie Citrome, MD, MPH, talks about asenapine, or SECUDADO, the first-and-only transdermal patch formulation for the treatment of adults with schizophrenia approved by the U.S. Food and Drug Administration.
Read more about the asenapine transdermal system
Dr Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Latest Alzheimer Disease Data: Reports from CTAD 2025
2
Competence and Compassion in the Reiner Family Tragedy
3
Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics
4
Psychiatry and Artificial Intelligence in 2025
5

















